James L. Trevaskis PhD

James is an experienced scientist with strong in vivo pharmacology background, with emphasis on identification and validation of novel targets for the potential treatment of metabolic diseases, particularly obesity, diabetes and NASH. He has significant experience in leveraging combination strategies for the treatment of metabolic diseases. He has led target discovery and validation, and drug development project teams throughout his 10 years in industry, including nomination of clinical development candidates.